Conformational changes and disease--serpins, prions and Alzheimer's. (Q53333352)

13 May 2018

review article

1 reference

title

Conformational changes and disease--serpins, prions and Alzheimer's. (English)

1 reference

13 May 2018

0 references

2

1 reference

13 May 2018

author name string

Carrell RW

series ordinal

1

1 reference

13 May 2018

publication date

1 December 1998

1 reference

13 May 2018

Current Opinion in Structural Biology

published in

1 reference

13 May 2018

volume

8

1 reference

13 May 2018

page(s)

799-809

1 reference

13 May 2018

issue

6

1 reference

13 May 2018

cites work

Conformational disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Prion diseases and the BSE crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

A new variant of prion disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Amyloid beta-protein and the genetics of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Amyloid beta threads in the fabric of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

An atlas of serpin conformations.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

What do dysfunctional serpins tell us about molecular mobility and disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Alternative conformations of amyloidogenic proteins govern their behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The prion folding problem.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Amyloid deposits and amyloidosis: the beta-fibrilloses (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

1 reference

7 January 2021

Characterization of the Amyloid Fibril as a Cross- Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

In vitro amyloid fibril formation from alpha 1-antitrypsin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

New clues to Alzheimer's disease: unraveling the roles of amyloid and tau.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Mapping the serpin-proteinase complex using single cysteine variants of alpha1-proteinase inhibitor Pittsburgh.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The mechanism of Z alpha 1-antitrypsin accumulation in the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Inhibitory conformation of the reactive loop of alpha 1-antitrypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Biological implications of a 3 A structure of dimeric antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

The anticoagulant activation of antithrombin by heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Structural basis of latency in plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Molecular evolution of plasminogen activator inhibitor-1 functional stability

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Characterization of a human alpha1-antitrypsin variant that is as stable as ovalbumin.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Self-replication and scrapie

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Prion Protein Biology

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

BSE and prions: uncertainties about the agent

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Prion research: the next frontiers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Autocatalytic processes in cooperative mechanisms of prion diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Alzheimer's disease. Tangle disentanglement.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Implications for function and therapy of a 2.9 A structure of binary-complexed antithrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Wild-type alpha 1-antitrypsin is in the canonical inhibitory conformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Haemoglobin Köln (β–98 Valine → Methionine): An Unstable Protein Causing Inclusion-Body Anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Increased body temperature accelerates aggregation of the Leu-68-->Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-440X%2898%2980101-2

7 January 2021

10.1016/S0959-440X(98)80101-2

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

9914261

1 reference

13 May 2018